What payment processor accepts peptide brands?

"What payment processor accepts peptide brands?" is the question operators Google at 2am after another shutdown. The honest list is shorter than most blog posts pretend. Here is who actually underwrites peptide brands in 2026, how each one behaves in year 1 vs year 2, and the structural choice that matters most.

1. Definitive no list

These processors will not underwrite peptide brands. Do not waste application cycles:

• Stripe — Restricted Businesses list excludes unapproved pharmaceuticals and research chemicals.
• Square — Same policy outcome; closures hit around month 2-4.
• PayPal / Braintree — AUP excludes drugs and drug paraphernalia.
• Shopify Payments — Stripe underneath in US.
• Amazon Pay — declines on category.
• Apple Pay on mainstream merchant IDs — requires underlying MID acceptance; re-registration needed on peptide-approved MIDs.

2. Definitive yes list (domestic)

ISOs with active peptide books in 2026, in rough order of how often we see them:

EasyPayDirect (Authorize.net gateway)

• Rate: 3.5-4.5% effective, interchange-plus preferred.
• Reserve: 10-15% rolling, 180 days.
• Setup: $0-$500.
• Contract: 2-3 years, $295 ETF.
• Underwriting: 5-10 business days.
• Strength: peptide is a named vertical, underwriting team is familiar.
• Caveat: chargeback threshold strict (0.75% pause).

PayKings (Authorize.net / NMI)

• Rate: 3.8-4.7% effective.
• Reserve: 15% rolling, 180 days.
• Strength: tighter fraud tooling via NMI Kount integration.
• Caveat: stricter SKU review; some research-chemical-adjacent products rejected.

Durango Merchant Services (Authorize.net)

• Rate: 3.5-4.4% effective.
• Reserve: 15-20% rolling, 180 days — higher for new accounts.
• Strength: experienced nutra/peptide desk.
• Caveat: reserves higher than average in year 1.

Corepay (Authorize.net)

• Rate: 3.8-4.8% effective.
• Reserve: 10-15% rolling, 180 days.
• Strength: nutra specialist, willing to co-underwrite multi-brand.
• Caveat: requires strong document package upfront.

Soar Payments, High Risk Pay

Both approve peptide. Rates and reserves similar to above. Read contracts carefully — monthly minimums and PCI fees vary more than the rate.

3. Offshore options

For operators over $300k/mo or those who have been closed domestically:

• Emerchantpay (EU) — 5-6% effective, 15-20% reserve, 360-day rolling release.
• Paynetics (EU) — specialty high-risk, peptide case-by-case.
• Global Payments Canada — if you have a Canadian entity, legitimately.

Tradeoffs: cross-border fees (1-2%), slower dispute resolution, currency conversion friction.

4. Parent-account consolidation (for multi-brand peptide operators)

If you run 3+ peptide brands under one parent entity, consolidating onto a single parent MID with orchestrated sub-brand descriptors collapses N underwriting relationships into 1. That is what multiflow orchestrates.

Structural differences vs. N separate ISO accounts:

• One underwriting vs. N.
• One reserve vs. N.
• One chargeback queue vs. N.
• Portfolio-level rate leverage.
• Sub-brand descriptors preserved per charge.

Concentration risk exists but is usually outweighed by ops simplification for operators above ~$150k/mo portfolio volume.

5. What separates sustainable approvals from 90-day closes

Document honesty at underwriting

Tell the ISO exactly what you sell, including any edge-case SKUs. Operators who omit research chemicals or "not-for-human-consumption" lines get closed when the post-approval SKU review catches them. Full disclosure at underwriting preserves the relationship even when it leads to a higher initial reserve.

Chargeback discipline

Peptide accounts live and die by chargeback ratio. Required tooling:

• Ethoca + Verifi alerts wired at launch (separate from the ISO deal).
• Descriptor match to brand name.
• AVS + CVV strict mode.
• Order confirmation emails with detailed order summary.
• Shipping confirmation with tracking.
• Signature on orders over $200.
• Fast customer service (under 4 business hour response).

See our peptide chargeback prevention playbook.

Volume predictability

Peptide ISOs set monthly volume caps on new accounts ($50-250k). If you exceed the cap, charges bounce or get held. Request cap lifts proactively at month 3-6 with clean history; do not surprise the underwriting team with a 5x volume spike.

Refund policy clarity

Ambiguous or operator-hostile refund policies trigger disputes. Post the policy above the fold, make it easy to request a refund, and process refunds quickly. Counterintuitively, a more generous refund policy reduces chargebacks significantly.

6. Our honest recommendation by operator size

• Single brand, under $80k/mo: EasyPayDirect or Corepay. Expect 8-10 day underwriting. Plan for the reserves.
• Single brand, $80-300k/mo: shop EasyPayDirect, PayKings, Durango in parallel. Pick on chargeback threshold + ETF.
• Multi-brand, 3+ peptide brands, any volume: parent-account consolidation usually wins on total cost of ownership.
• Post-closure / MATCH-listed: offshore acquirer + parent-account consolidation, read the MATCH playbook first.

Next step

If you run multi-brand peptide and want an honest structural answer (not an ISO referral commission), apply in 12 questions. 48-hour honest response including cases where we recommend an ISO.